Cellular tumor antigen p53
Cellular tumor antigen p53 (153-165) is a synthetic peptide fragment corresponding to residues 153 through 165 of the human p53 protein, a pivotal tumor suppressor involved in cell cycle regulation, DNA repair, and apoptosis. This peptide segment is derived from the DNA-binding domain of p53, a region essential for its transcriptional activity and interaction with regulatory partners. By mimicking a defined epitope within the larger p53 structure, the peptide serves as a valuable molecular tool for elucidating protein-protein interactions, mapping antigenic determinants, and advancing the understanding of p53's functional dynamics in cellular processes. Its precise sequence and biochemical properties make it a key reagent in studies focused on cancer biology, immunology, and the molecular mechanisms underlying p53-mediated cellular responses.
Epitope mapping: Researchers frequently employ the 153-165 fragment of p53 in epitope mapping studies to identify and characterize antibody binding sites within the p53 protein. By using this defined peptide as an antigen in immunoassays, scientists can determine the specificity and affinity of monoclonal or polyclonal antibodies against p53, facilitating the development of highly selective reagents for diagnostic or research applications. This approach is instrumental in dissecting immune recognition patterns and in validating antibody performance in various assay formats.
Protein interaction studies: The peptide is instrumental in probing the molecular interactions between p53 and its cellular partners. Its sequence, located within the DNA-binding core, is critical for mediating contacts with regulatory proteins such as MDM2, which modulates p53 stability and activity. By incorporating the 153-165 peptide into binding assays, pull-down experiments, or surface plasmon resonance analyses, researchers can dissect the binding interfaces and affinities of p53-interacting proteins, supporting drug discovery and mechanistic investigations into tumor suppressor regulation.
T-cell response analysis: The 153-165 region of p53 encompasses a known immunogenic epitope that can be presented by major histocompatibility complex (MHC) molecules to cytotoxic T lymphocytes. In immunological research, this peptide is utilized to stimulate T-cell cultures, assess antigen-specific cellular immune responses, and evaluate the repertoire of p53-reactive T cells in various experimental settings. These studies are crucial for understanding immune surveillance mechanisms and the role of p53-derived peptides in tumor immunology.
Peptide-based assay development: The defined sequence of the 153-165 peptide enables its use as a standard or calibrator in a range of biochemical assays. It can be incorporated into enzyme-linked immunosorbent assays (ELISAs), western blots, or mass spectrometry protocols to quantify p53-specific antibodies, validate assay sensitivity, or serve as a positive control. Its stability and well-characterized structure make it suitable for optimizing assay conditions and ensuring reproducibility across experimental workflows.
Structure-function analysis: Employing the 153-165 peptide allows researchers to investigate the structural determinants underlying p53's biological functions. By analyzing how modifications within this segment affect folding, DNA binding, or interaction with other proteins, scientists can gain insights into the critical residues required for p53 activity. Such studies contribute to a deeper understanding of the molecular basis of tumor suppression and inform the design of functional analogs or inhibitors targeting the p53 pathway.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More